Research line
Metabolic, recovery, aesthetic and longevity research peptides, plus bacteriostatic water for reconstitution. Each entry states what it is and what it's been studied for — no more than that.
Research use only. These compounds are supplied for laboratory and research purposes. They are not intended to diagnose, treat, cure or prevent any disease, and statements on this page have not been evaluated by the FDA.
An investigational peptide activating GLP-1, GIP and glucagon receptors simultaneously. Studied for appetite regulation, blood sugar control, satiety and the body's use of stored fat.
The first dual incretin receptor agonist of its kind, mimicking two hormones involved in blood sugar regulation and appetite control. Studied for sustained weight reduction and metabolic markers.
A synthetic peptide derived from a protective sequence found in gastric juice. Preclinical work has examined tissue repair, angiogenesis and inflammatory response after injury. Human clinical evidence remains limited.
A naturally occurring peptide involved in tissue maintenance, cell migration and wound healing. Widely studied in sports medicine and regenerative contexts; many applications remain investigational.
BPC-157 and Thymosin Beta-4 together — commonly paired because they are thought to act on complementary repair pathways. The name is a marketing nickname, not a scientific term.
A modified analog of naturally occurring insulin-like growth factor-1, designed for extended biological activity in research settings. The LR3 modification alters its interaction with IGF-binding proteins, making it a compound of interest for investigating sustained IGF-1 receptor signalling and anabolic cellular pathways. Research has explored its potential effects on skeletal muscle cells, protein metabolism, tissue development and recovery-related signalling. It remains an investigational research compound, and its effects and safety have not been established for general therapeutic use.
A naturally occurring copper-binding peptide that acts as a signalling molecule in tissue remodelling, collagen production and cellular renewal. Natural levels decline with age.
A blend combining GHK-Cu for collagen and skin remodelling, BPC-157 for connective tissue and Thymosin Beta-4 for cellular repair — a multi-pathway approach to skin and recovery.
A multi-peptide formulation bringing together complementary regenerative peptides rather than targeting a single pathway. Studied for connective tissue health, skin quality and cellular recovery.
Activates melanocortin receptors in the central nervous system rather than acting on blood flow. Bremelanotide is FDA-approved for acquired, generalised HSDD in premenopausal women; other uses continue to be studied.
Sterile, non-pyrogenic water with 0.9% benzyl alcohol as a bacteriostatic preservative, allowing multiple withdrawals from one vial under proper aseptic technique. A diluent only — contains no active compound.
Everything above, side by side.
| Compound | Category | Common research areas | Best for |
|---|---|---|---|
| Retatrutide | Metabolic | Appetite regulation, glucose control, fat metabolism | Advanced metabolic research |
| Tirzepatide | Metabolic | Appetite regulation, insulin sensitivity, weight management | Weight management research |
| BPC-157 | Recovery | Tissue repair, tendons, ligaments, gastrointestinal | Injury and recovery research |
| Thymosin Beta-4 | Recovery | Cellular repair, tissue regeneration, wound healing | Healing research |
| Wolverine Stack | Recovery | Connective tissue, post-exercise recovery, inflammation | Comprehensive recovery research |
| IGF-1 LR3 | Recovery | Cellular growth, protein synthesis, muscle development, tissue recovery | Muscle growth and recovery research |
| GHK-Cu | Aesthetics | Collagen synthesis, skin appearance, hair follicles | Healthy aging research |
| GLOW | Aesthetics | Skin quality, tissue health, whole-body recovery | Beauty and recovery research |
| KLOW | Longevity | Tissue repair, collagen, cellular communication | Healthy aging research |
| PT-141 (Bremelanotide) | Wellness | Melanocortin receptor research, sexual wellness | Sexual wellness research |
| Bacteriostatic Water | Supplies | Peptide reconstitution and preparation | Mixing and preparation |
Common questions
Research-use terms, eligibility and returns are covered on the full FAQ.
Eleven compounds grouped by research area — metabolic, recovery, aesthetics, longevity and wellness — plus bacteriostatic water as a preparation supply. They include Retatrutide, Tirzepatide, BPC-157, Thymosin Beta-4, IGF-1 LR3, GHK-Cu, PT-141 and the GLOW, KLOW and Wolverine Stack blends. Each entry states what it is and what it has been studied for.
Use the enquiry form on this page. It goes straight to the peptide line rather than a general inbox, and most enquiries are answered within one business day with purity documentation and availability for the compound you asked about. You can ask about batch testing and presentation in the same message.
A blend combines compounds thought to act on complementary pathways rather than one alone. The Wolverine Stack pairs BPC-157 with Thymosin Beta-4; GLOW combines GHK-Cu, BPC-157 and TB-500; KLOW is a multi-peptide longevity formulation. Those names are marketing nicknames rather than scientific terms, and every entry is supplied for research use only.
The line is supplied for laboratory and research use, not as approved medicines, and no statement on this page has been evaluated by the FDA. One active ingredient does hold an approval in a separate context: bremelanotide is FDA-approved for acquired, generalised hypoactive sexual desire disorder in premenopausal women. Other uses continue to be studied.
Peptide enquiry
Ask about purity documentation, batch testing, presentation and availability. This goes straight to the peptide line — not a general inbox.
USBio